Cynapsus Therapeutics Awarded Second Grant from The Michael J. Fox Foundation for Parkinson's Research

(July 11, 2014) - The Michael J. Fox Foundation for Parkinson's Research (MJFF) has awarded $500,000 to Cynapsus Therapeutics to support clinical studies to develop APL-130277, a sublingual thin film strip reformulation of apomorphine. This second MJFF grant will be used to fund the Company's CTH-105 clinical study. Read more…